ACCELERON PHARMA INC Insider Trading for September 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACCELERON PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACCELERON PHARMA INC for September 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 18 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 34.96 | 400 | 13,984 | 9,700 | 10.1 K to 9.7 K (-3.96 %) |
| Sep 18 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 34.93 | 200 | 6,986 | 96,404 | 96.6 K to 96.4 K (-0.21 %) |
| Sep 18 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 33.55 | 300 | 10,065 | 96,604 | 96.9 K to 96.6 K (-0.31 %) |
| Sep 18 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 32.22 | 1,100 | 35,442 | 96,904 | 98 K to 96.9 K (-1.12 %) |
| Sep 16 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 5.28 | 2,000 | 10,560 | 32,307 | |
| Sep 16 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 33.61 | 2,000 | 67,220 | 119,656 | 121.7 K to 119.7 K (-1.64 %) |
| Sep 16 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 5.28 | 2,000 | 10,560 | 121,656 | 119.7 K to 121.7 K (+1.67 %) |
| Sep 16 2015 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Option Exercise | M | 3.88 | 11,485 | 44,562 | 13,515 | |
| Sep 16 2015 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Sell | S | 35.00 | 33,000 | 1,155,000 | 56,685 | 89.7 K to 56.7 K (-36.80 %) |
| Sep 16 2015 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Buy | M | 3.88 | 11,485 | 44,562 | 89,685 | 78.2 K to 89.7 K (+14.69 %) |
| Sep 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Option Exercise | M | 3.88 | 5,500 | 21,340 | 22,000 | |
| Sep 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Sell | S | 34.17 | 1,400 | 47,838 | 76,123 | 77.5 K to 76.1 K (-1.81 %) |
| Sep 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Sell | S | 33.07 | 4,100 | 135,587 | 77,523 | 81.6 K to 77.5 K (-5.02 %) |
| Sep 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Buy | M | 3.88 | 5,500 | 21,340 | 81,623 | 76.1 K to 81.6 K (+7.23 %) |
| Sep 15 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 0.40 | 8,500 | 3,400 | 0 | |
| Sep 15 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 0.40 | 8,500 | 3,400 | 119,084 | 110.6 K to 119.1 K (+7.69 %) |
| Sep 11 2015 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Grant | A | 0.00 | 40,000 | 0 | 78,200 | 38.2 K to 78.2 K (+104.71 %) |
| Sep 11 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Grant | A | 0.00 | 40,000 | 0 | 76,123 | 36.1 K to 76.1 K (+110.73 %) |
| Sep 11 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Grant | A | 0.00 | 46,000 | 0 | 98,004 | 52 K to 98 K (+88.45 %) |
| Sep 11 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Grant | A | 0.00 | 62,000 | 0 | 119,656 | 57.7 K to 119.7 K (+107.53 %) |
| Sep 11 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Grant | A | 0.00 | 40,000 | 0 | 80,000 | 40 K to 80 K (+100.00 %) |
| Sep 11 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Grant | A | 0.00 | 89,000 | 0 | 110,584 | 21.6 K to 110.6 K (+412.34 %) |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 1,500 | 5,820 | 35,751 | |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 5,000 | 19,400 | 37,251 | |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 31.16 | 176 | 5,484 | 40,000 | 40.2 K to 40 K (-0.44 %) |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 30.45 | 724 | 22,046 | 40,176 | 40.9 K to 40.2 K (-1.77 %) |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 29.39 | 600 | 17,634 | 40,900 | 41.5 K to 40.9 K (-1.45 %) |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 1,500 | 5,820 | 41,500 | 40 K to 41.5 K (+3.75 %) |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 31.07 | 1,293 | 40,174 | 40,000 | 41.3 K to 40 K (-3.13 %) |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 30.22 | 2,500 | 75,550 | 41,293 | 43.8 K to 41.3 K (-5.71 %) |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 29.11 | 1,207 | 35,136 | 43,793 | 45 K to 43.8 K (-2.68 %) |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 5,000 | 19,400 | 45,000 | 40 K to 45 K (+12.50 %) |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 5.08 | 19,000 | 96,520 | 221,133 | |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 31.06 | 5,173 | 160,673 | 21,584 | 26.8 K to 21.6 K (-19.33 %) |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 30.27 | 9,028 | 273,278 | 26,757 | 35.8 K to 26.8 K (-25.23 %) |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 29.16 | 4,799 | 139,939 | 35,785 | 40.6 K to 35.8 K (-11.82 %) |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 5.08 | 19,000 | 96,520 | 40,584 | 21.6 K to 40.6 K (+88.03 %) |